Physician profile
Jaime Mckeever
NPI 1346433935
$360.03
in general payments reported to CMS, 2019-2025
10 companies · $85.84 in 2025
The $85.84 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.43 · 2020: $20.70 · 2021: $14.11 · 2022: $19.91 · 2023: $96.20 · 2024: $92.84 · 2025: $85.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $87.13 | 2020-2025 | |
| Pfizer INC. | $75.15 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $51.75 | 2023-2025 | Qelbree, Qelbree |
| Acadia Pharmaceuticals INC | $40.50 | 2024 | Nuplazid |
| Ironshore Pharmaceuticals INC. | $23.05 | 2024 | |
| Lnhc, INC | $21.80 | 2025 | Zelsuvmi |
| Hologic Sales and Service, LLC | $16.11 | 2023 | Aptima, Thinprep 2000 Processor |
| Kaleo, INC. | $15.28 | 2019 | |
| Shire North American Group INC | $15.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Mckeever listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.